Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation of aqueous clear solution dosage forms with bile acids

A technology for bile acids and bile salts is applied in the field of preparation of clear aqueous solutions containing bile acids, and can solve the problems of insufficient delivery of active agents, non-specific toxicity to organs and the like

Inactive Publication Date: 2009-11-11
柳署弘
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0032] Drug delivery systems involving bile acids can provide liver-specific drug targeting, an important direction for drug development, as standard pharmacological approaches to treating liver disease have suffered from insufficient delivery of active agents into liver cells , and nonspecific toxicity to other organs
Unfortunately, bismuth concentrations in mucus are often lower than the average inhibitory effect of H. concentration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of aqueous clear solution dosage forms with bile acids
  • Preparation of aqueous clear solution dosage forms with bile acids
  • Preparation of aqueous clear solution dosage forms with bile acids

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0097] The stability of the formulations of the invention was evaluated by measuring the time change in the concentration of the relevant bile acids in formulations comprising soluble bile acids, high molecular weight water-soluble starch conversion products, and water at different pH and temperature levels. The retention time for each bile acid can be adjusted as desired to allow analysis of individual bile acids in the composite example, ie, the example with multiple bile acids.

[0098] Stability tests were performed with three different aqueous systems:

[0099] 1. According to embodiment 1, bile acid and polymer water-soluble starch conversion product are mixed in aqueous solution, and the results are shown in Table 1A and 1B.

[0100] 2. According to Example II, the mixed bile acid and the polymer water-soluble starch conversion product were mixed in the aqueous solution, and the results are shown in Table 2.

[0101]3. According to Example IV, bile acid, high molecular...

Embodiment I

[0107] Solution formulations prepared as follows were tested without any precipitation at any pH tested.

[0108] Soluble bile acid 200mg (free acid)

[0109] Minimum amount of maltodextrin for CDCA: about 30g;

[0110] For UDCA: about 5g;

[0111] For 7-ketolithocholic acid: about 12 g;

[0112] For cholic acid: about 10 g;

[0113] For deoxycholic acid: about 50 g;

[0114] For hyodeoxycholic acid: about 3.5 g

[0115] Purified water 100mL

[0116] Prepare a solution with 100 mL of an aqueous solution of the above-mentioned bile acid. Maltodextrin, a high molecular weight water-soluble starch conversion product, is added to the resulting clear solution at room temperature with stirring. Add purified water to adjust the volume to 100 mL. Purified water was deionized water, deionized distilled water, or general pharmaceutical preparation grade water as developed at any time and in all examples.

[0117] According to these formulas, certain bile acids (or salts) contai...

Embodiment II

[0119] The following solution dosage forms were prepared according to the following principles, and they did not undergo any precipitation at any pH.

[0120] Soluble bile acid 200mg (free acid),

[0121] Soluble 7-ketolithocholic acid 200mg (free acid),

[0122] Soluble chenodeoxycholic acid 200mg (free acid),

[0123] The minimum amount of maltodextrin 40g, and

[0124] Purified water 100mL

[0125] Prepare 60 mL of an aqueous solution in which soluble cholic acid, 7-ketolithocholic acid, and soluble chenodeoxycholic acid are dissolved. Maltodextrin was added to the resulting clear aqueous solution with stirring at room temperature. Add purified water to adjust the volume to 100 mL.

[0126] Using this formulation, stability tests in aqueous solutions of different bile acid mixtures with controllable hydrophilicity and hydrophobicity control were performed.

[0127] Table 1A shows the test results of the stability of CA, 7-ketolithocholic acid, CDCA, and DCA formulatio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
Login to View More

Abstract

Compositions for pharmaceutical and other uses comprising clear aqueous solutions of bile acids which do not form any detectable precipitates over selected ranges of pH values of the aqueous solution and methods of making such solutions. The compositions of the invention comprise water; a bile acid in the form of a bile acid, bile acid salt, or a bile acid conjugated with an amine by an amide linkage; and either or both an aqueous soluble starch conversion product and a aqueous soluble non-starch polysaccharide. The composition remains in solution without forming a precipitate over a range of pH values and, according to one embodiment, remains in solution for all pH values obtainable in an aqueous system. The composition, according to some embodiments, may further contain a pharmaceutical compound in a pharmaceutically effective amount. Non-limiting examples of pharmaceutical compounds include insulin, heparin, bismuth compounds, amantadine and rimantadine.

Description

Background of the invention [0001] Bile salts are organic acids derived from cholesterol, which are natural ionic detergents and play key roles in the absorption, transport and secretion of lipids. In bile acid chemistry, the steroid nucleus of bile salts has a hydrocyclopentaphenanthrene nucleus common to all perhydrosteroid compounds. Distinguishing features of bile acids include a saturated 19-carbon steroid nucleus, a beta hydrogen at the 5-position, a saturated branched 5-carbon side chain terminating in a carboxylic acid, and an alpha hydroxyl at the 3-position. The only substituent present in most natural bile acids is the hydroxyl group. In most mammals, the hydroxyl group is at the 3, 6, 7 or 12 position. [0002] General bile acids differ mainly in the number of hydroxyl groups on the sterol ring and the nuclear orientation. The term primary bile acids refers to bile acids de novo synthesized by the liver. In humans, primary bile acids include cholic acid (3α, 7α...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/36A61K9/08A61K31/575A61P1/16A61K9/06A61K8/00A61K8/63A61K8/72A61K8/73A61K9/00A61K9/10A61K33/24A61K45/06A61K47/04A61K47/12A61K47/14A61K47/18A61K47/28A61K47/32A61K47/38A61P1/02A61P1/04A61P3/06A61P35/00A61Q11/00
CPCA61K9/0019A61K9/08A61K9/0095A61K31/575A61K47/28A61K9/06A61K9/0014A61K9/0056A61K47/36A61K45/06A61P1/02A61P1/04A61P1/16A61P35/00A61P3/06A61K47/00
Inventor 柳署弘
Owner 柳署弘